| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 5.746 | 27.829 | 3.432 | 0 | 0 | - | - |
| Total Income - EUR | - | - | 0 | 14.494 | 35.885 | 12.137 | 7.728 | 3.230 | - | - |
| Total Expenses - EUR | - | - | 0 | 14.423 | 17.246 | 12.091 | 7.802 | 7.811 | - | - |
| Gross Profit/Loss - EUR | - | - | 0 | 72 | 18.639 | 46 | -74 | -4.581 | - | - |
| Net Profit/Loss - EUR | - | - | 0 | 14 | 18.368 | 13 | -74 | -4.581 | - | - |
| Employees | - | - | 0 | 2 | 2 | 1 | 0 | 0 | - | - |
Check the financial reports for the company - Thera Natura Laborator Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.829 | 29.857 | 21.223 | 12.928 | 4.913 | 72 | - | - |
| Current Assets | - | - | -34 | 8.355 | 23.044 | 23.109 | 22.523 | 122 | - | - |
| Inventories | - | - | 0 | 3.052 | 2.993 | 2.936 | 2.871 | 0 | - | - |
| Receivables | - | - | 0 | 2.605 | 2.573 | 2.822 | 2.759 | 0 | - | - |
| Cash | - | - | -34 | 2.698 | 17.478 | 17.351 | 16.892 | 122 | - | - |
| Shareholders Funds | - | - | 44 | 57 | 18.424 | 18.088 | 17.613 | -1.033 | - | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | - | 1.751 | 5.322 | 1.701 | 2.168 | 2.120 | 1.227 | - | - |
| Income in Advance | - | - | 0 | 32.834 | 24.142 | 15.781 | 7.703 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Thera Natura Laborator Srl-D